Cargando…
History and emerging trends in chemotherapy for gastric cancer
Chemotherapy is indispensable for gastric cancer. For unresectable and/or recurrent gastric cancer, first‐line chemotherapy consists of multidrug regimens including oral 5‐FU agents such as S1/Xeloda and platinum preparations, as well as Trastuzumab, which is effective in HER2‐positive cases. Second...
Autores principales: | Yamashita, Keishi, Hosoda, Kei, Niihara, Masahiro, Hiki, Naoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316740/ https://www.ncbi.nlm.nih.gov/pubmed/34337293 http://dx.doi.org/10.1002/ags3.12439 |
Ejemplares similares
-
Postoperative pancreatic fistula after gastrectomy for gastric cancer
por: Washio, Marie, et al.
Publicado: (2020) -
Robot‐assisted minimally invasive esophagectomy for esophageal cancer: Meticulous surgery minimizing postoperative complications
por: Hosoda, Kei, et al.
Publicado: (2020) -
Early administration of postoperative BCAA-enriched PPN may improve lean body mass loss in gastric cancer patients undergoing gastrectomy
por: Sakuraya, Mikiko, et al.
Publicado: (2023) -
Prospective study to validate the clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer
por: Harada, Hiroki, et al.
Publicado: (2021) -
Re‐emerging role of macroscopic appearance in treatment strategy for gastric cancer
por: Hosoda, Kei, et al.
Publicado: (2018)